GET THE APP

Molecular targeting of cancer stem cells by the small molecule dichloroacetate (DCA) through the disruption of the OCT4/PKM2 complex
..

Cancer Science & Therapy

ISSN: 1948-5956

Open Access

Molecular targeting of cancer stem cells by the small molecule dichloroacetate (DCA) through the disruption of the OCT4/PKM2 complex


International Conference & Exhibition on Cancer Science & Therapy

15-17 August 2011 Las Vegas, USA

Francois M. Vallette

INSERM and Universit├?┬ę de Nantes, France

Scientific Tracks Abstracts: J Cancer Sci Ther

Abstract :

It has been postulated that solid tumors originate from a relatively small number of cells called cancer stem cells (CSC). Numerous studies have shown that brain tumor cancer stem cells were highly resistant to cell death and as such might contribute to tumor recurrence by eluding anti-cancer treatments. Like neural stem cells, cancer stem cells form in vitro structures called neurospheres. Using a proteomic approach based on two-dimensional DIGE and MALDI-TOF/TOF mass spectrometric identification, we have compared neurospheres derived from rat neural stem cells (NSC) with that derived from rat glioma (CSC) . The major pathway highlighted by this proteomic analysis is glucose metabolism. Inhibition of aerobic glycolysis in vitro altered the survival of CSC but not that of NSC. Strikingly, decreasing the non-oxidative glucose metabolism by Dichloroacetate (DCA), a PDK inhibitor, specifically depleted the stem cells population and impaired the growth of tumors in vivo. We found that DCA induced CSC differentiation rather than death, through the disruption of a PKM2/OCT4 complex in rat and human glioma. This work has important implications in the treatment of human brain tumors.

Biography :

François M. Vallette has completed his Ph.D at the age of 26 years from Paris VII University and did postdoctoral studies in the Department of Cell Biology of NYU Medical Center. Currently, he is the director of the Department of Oncogenesis and Targeted Therapies in the Nantes Angers Cancer Research Center in France. He has published more than 80 papers in reputed journals and serving as associate or editorial board member in several journals.

Google Scholar citation report
Citations: 3644

Cancer Science & Therapy received 3644 citations as per Google Scholar report

Cancer Science & Therapy peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward